These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sclerodermatous chronic graft-versus-host disease induced by host T-cell-mediated autoimmunity. Lee YJ; Min HS; Kang EH; Park HJ; Jeon YK; Kim JH; Wu HG; Lee EB; Park CG; Yoon SS; Park SH; Jung KC Immunol Cell Biol; 2012 Mar; 90(3):358-67. PubMed ID: 21625251 [TBL] [Abstract][Full Text] [Related]
3. Suppressor mechanisms active in the control of graft-v-host disease. Tutschka PJ Transplant Proc; 1987 Dec; 19(6 Suppl 7):69-74. PubMed ID: 2962355 [No Abstract] [Full Text] [Related]
4. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice. Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786 [TBL] [Abstract][Full Text] [Related]
5. Third-party tolerogenic dendritic cells reduce allo-reactivity in vitro and ameliorate the severity of acute graft-versus-host disease in allo-bone marrow transplantation. Yang J; Li R; Ren Y; Yang Y; Xie R; Fan H Scand J Immunol; 2013 Dec; 78(6):486-96. PubMed ID: 24283771 [TBL] [Abstract][Full Text] [Related]
6. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. Truitt RL; Atasoylu AA Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016 [TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease. Bladon J; Taylor P Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119 [TBL] [Abstract][Full Text] [Related]
8. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Li JM; Waller EK Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum. Oluwole SF; Engelstad K; Hardy MA Transplant Proc; 1992 Dec; 24(6):2858-9. PubMed ID: 1465974 [No Abstract] [Full Text] [Related]
10. Host CD8α+ dendritic cells may be a key factor for separating graft-versus-host disease from graft-versus-leukemia. Toubai T; Mathewson N; Oravecz-Wilson K; Reddy P Biol Blood Marrow Transplant; 2015 Apr; 21(4):775-6. PubMed ID: 25591846 [No Abstract] [Full Text] [Related]
11. Reconstructing immunity after allogeneic transplantation. Giver CR; Li JM; Hossain MS; Lonial S; Waller EK Immunol Res; 2004; 29(1-3):269-82. PubMed ID: 15181288 [TBL] [Abstract][Full Text] [Related]
12. Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation Period. Inoue T; Ikegame K; Kaida K; Okada M; Yoshihara S; Tamaki H; Fujimori Y; Soma T; Ogawa H J Immunol; 2016 Jan; 196(1):469-83. PubMed ID: 26621858 [TBL] [Abstract][Full Text] [Related]
13. T-cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment, and graft-versus-leukemia. Champlin R J Hematother; 1993; 2(1):27-42. PubMed ID: 7921964 [No Abstract] [Full Text] [Related]
14. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation. Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of interleukin-18 receptor on T lymphocytes in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. Fujimori Y; Yoshimoto T; Matsui K; Tsutsui H; Okamoto T; Kashiwamura S; Hada T; Okamura H; Kakishita E; Hara H; Nakanishi K J Interferon Cytokine Res; 2002 Jul; 22(7):751-4. PubMed ID: 12184912 [TBL] [Abstract][Full Text] [Related]
16. T cell subsets controlling graft-v-host disease in mice. Sprent J; Korngold R Transplant Proc; 1987 Dec; 19(6 Suppl 7):41-7. PubMed ID: 3501190 [No Abstract] [Full Text] [Related]
17. Tbet is a critical modulator of FoxP3 expression in autoimmune graft- Amarnath S; Laurence A; Zhu N; Cunha R; Eckhaus MA; Taylor S; Foley JE; Ghosh M; Felizardo TC; Fowler DH Haematologica; 2017 Aug; 102(8):1446-1456. PubMed ID: 28473623 [TBL] [Abstract][Full Text] [Related]
18. Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation. Weerasinghe A; Kawamura T; Moroda T; Seki S; Watanabe H; Abo T Cell Immunol; 1998 Apr; 185(1):14-29. PubMed ID: 9636679 [TBL] [Abstract][Full Text] [Related]
19. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183 [TBL] [Abstract][Full Text] [Related]
20. Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease. Tsoi MS; Dobbs S; Brkic S; Ramberg R; Thomas ED; Storb R Transplantation; 1984 Jun; 37(6):556-61. PubMed ID: 6233768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]